The role of vitamin D in systemic lupus erythematosus
Keywords:
Immune system, Systemic lupus erythematosus, Vitamin DAbstract
In addition to its role in calcium homeostasis, it is believed that the active form of vitamin D has immunomodulatory effects, suppressing or activating the immune system. Recent studies have linked vitamin D deficiency or insufficiency with multiple autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes Mellitus and multiple sclerosis. Thus, the present review describes vitamin D metabolism and its functions, emphasizing its action on the immune system as well as its participation in systemic lupus erythematosus. All evidence focuses on the relationship between low vitamin D levels and the
clinical manifestation of systemic lupus erythematosus, but it is not yet clear whether supplementation or reestablishment of normal levels can influence disease activity. Thus, more studies are needed to assess the possible therapeutic benefits of vitamin D supplementation on systemic lupus erythematosus.
References
Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29(6):726-76.
Jones BJ, Twomey PJ. Issues with vitamin D in routine clinical practice. Rheumatol. 2008; 47(9): 1267-68.
Lemire JM, Ince A, Takashima M. 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/1 mice. Autoimmunity. 1992; 12(2):143-8.
Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr. 2004; 79(3):362-71.
Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci. 2007; 1109:385-400.
Lima I, Néri F, Santiago MB. Dosagem sérica de adenosina deaminase em lúpus eritematoso sistêmico: ausência de associação com atividade de doença. Rev Bras Reumatol. 2005; 45(5):273-9.
Kamen DL, Aranow C. The link between vitamin D deficiency and systemic lupus erythematosus. Curr Rheumatol Rep. 2008; 10(4):273-80.
Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new etiological and therapeutic considerations. Ann Rheum Dis. 2007; 66(9): 1137-42.
Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004; 80(6 Suppl):1678S-88S.
Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, editors. Williams textbook of endocrinology. Philadelphia: Elsevier; 2008. v.11.
Leventis P, Patel S. Clinical aspects of vitamin D in the management of rheumatoid arthritis. Rheumatol. 2008; 47(11):1617-21.
Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metabol. 2006; 50(4):640-6.
National Academy of Sciences. Recommended Dietary Allowances [Internet]. Washington (DC): NAS; 1989 [cited 2010 Dec 15]. Avalilable from: <http://www.nap.edu/catalog.php?record_id=1349>.
Institute of Medicine. Dietary reference intake for calcium, phosphorus, magnesium, vitamin d and fluoride [Internet]. Washington (DC): IOM; 1997 [cited 2011 May 1]. Available from: <http://www.nap.edu/catalog.php?record_id=5776>.
Pittard WB, Geddes KM, Hulsey TC, Hollis BW. How much vitamin D for neonates? Am J Dis Child. 1991; 145(10):1147-9.
Datta S, Alfaham M, Davies DP, Dunstan F, Woodhead S, Evans J, et al. Vitamin D deficiencyin pregnant women from a non-European ethnic minority population: an international study. Br J Obstet Gyneaecol. 2002; 109(8):905-8.
Institute of Medicine. Dietary reference intakes for calcium and vitamin D [Internet]. Washington (DC): IOM; 2010 [cited 2011 May 10]. Available from: <http://www.iom.edu/Reports/2010/DietaryReference-Intakes-for-Calcium-and-VitaminD.aspx>.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999; 69(5):842-56.
Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005; 16(7):713-6.
Chesney RW. Vitamin D and the magic mountain: the anti-infectious role of the vitamin. J Pediatr. 2010; 156(5):698-703 .
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009; 19(2):73-8.
Devlin TM. Princípios de nutrição II: micronutrientes. In: Stephen GC, editor. Manual de bioquímica com correlações clínicas. São Paulo: Edgard Blücher Ltda; 2003. v.5.
Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983; 57(6): 1308-10.
Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983; 221(4616):1181-3.
Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008; 4(8):404-12.
Maskin M. La vitamina D, el sistema inmune y lãs enfermedades de la piel. Educ Med. 2009; 15(6): 401-09.
Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol. 2008; 68(3):261-9.
D’Cruz DP, Khamashta MA, Hughes GR. Systemic Lupus Erythematosus. Lancet. 2007; 369(9561): 587-96.
Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010; 39(4):257-68.
Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus. 2008; 17(1):6-10.
Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatol. 2008; 47(6):920-3;
Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2009; 20(3):427-33.
Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006; 5(2):114-7.
Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y. Antivitamin D in SLE: preliminary results. Ann N Y Acad Sci. 2007; 1109:550-7.
Kim HA, Sung JM, Jeon JY, Yoon JM, Suh CH. Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol Int. 2011; 31(9): 1189-94.
Souto M, Coelho A, Guo C, Mendonça L, Argolo S, Papi J, et al. Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus. 2011; 20(10): 1019-26.
Fragoso TS, Dantas AT, Marques CDL, Rocha Junior LF, Melo JHL, Costa AJG, et al. Níveis séricos de 25-HydroxivitaminaD3 e a sua associação com parâmetros clínicos e laboratoriais em pacientes com lúpus eritematoso sistêmico. Rev Bras Reumatol. 2012; 52(1)60-5.
Clinical Trials Studies. Vitamin D3 in systemic lupus erythematosus [Internet]. 2011 [cited 2011 May 10]. Available from: <http://clinicaltrials.gov/ct2/show/NCT00710021>.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Thaisa de Mattos TEIXEIRA, Célia Lopes da COSTA
This work is licensed under a Creative Commons Attribution 4.0 International License.
